Thalamic-MPFC Connectivity Linked to Individual Differences in Impulsivity
A new study identifies specific thalamic subregions connected to the medial prefrontal cortex as structural correlates of delay discounting.
CCL19 Tracks IgG4-Related Disease Activity, Supplements IgG4 Levels
A new study identifies C-C motif chemokine ligand 19 as a dynamic serum biomarker for monitoring IgG4-RD treatment response and relapse.
IDH1 Mutations in Prostate Cancer Link High Stage/Grade to Favorable Outcomes
A retrospective analysis identifies IDH1 mutations as a marker for improved survival in prostate cancer, despite aggressive initial presentation.
CPES Score May Better Identify PE Patients Needing Advanced Intervention
A retrospective study suggests the Composite Pulmonary Embolism Shock score offers improved prediction for advanced interventions in PE.
CPES Score Identifies PE Patients Needing Advanced Intervention
A retrospective study finds the Composite Pulmonary Embolism Shock score particularly effective in predicting the need for advanced therapies.
Parkinson's Dementia Risk Lower, Later Than Prior Estimates
New data from the Parkinson's Progression Markers Initiative refines understanding of cognitive decline prevalence and progression.
Dual PH Therapy Before BPA Reduces Complications, Improves Outcomes in CTEPH
A Dutch registry study indicates that dual pulmonary hypertension-targeted medical therapy improves safety and efficacy of balloon pulmonary angioplas
Dual PH-Targeted Therapy Reduces BPA Complications, Improves Outcomes in CTEPH
A Dutch registry study indicates that dual pulmonary hypertension-targeted medical pretreatment lowers periprocedural risks and enhances clinical bene
Familial Brain Pattern Similarity Links to Psychotic Disorder Risk in Offspring
A new index quantifying cortical thickness similarity between parents with psychosis and their offspring correlates with psychiatric diagnoses.
Circulating Tumor DNA Predicts Progression-Free Survival in Hodgkin Lymphoma
A validated sequencing assay identifies patients at high risk for relapse after two cycles of chemotherapy in the GHSG HD21 trial.
CMR and NT-proBNP Improve Risk Prediction in Hypertrophic Cardiomyopathy
A prospective registry study identifies myocardial scar and natriuretic peptide levels as key predictors of long-term adverse outcomes.
Memory Deficits Persist in Multiple Sclerosis Despite Preserved Processing Speed
Modern treatment eras show a shift where cognitive slowing is no longer the primary deficit in relapsing-remitting multiple sclerosis.